In an observational study, physician perception of risk was not always consistent with evidence-based measures.
Clinical trial findings and guidelines support an early invasive strategy for high-risk patients with non–ST-segment-elevation MI, but prior studies have shown that many high-risk NSTEMI patients do not undergo early angiography. To explore why this occurs, investigators studied data from the Canadian Acute Coronary Syndromes Registry II on 2136 patients presenting with NSTEMI between October 1, 2002, and December 31, 2003. In this registry, when a patient was not referred for in-hospital angiography, the physician responsible for the decision was asked why.
Compared with patients who did not undergo angiography, those who did had lower in-hospital mortality (0.8% vs. 3.7%), 1-year mortality (4.0% vs. 10.9%), and 1-year rate of death or rein…
Reviewing Author
DisclosuresConsultant/Advisory BoardBristol Myers Squibb; CPC Clinical Research
Grant/Research SupportNational Heart, Lung, and Blood Institute
Editorial BoardsUpToDate; American College of Cardiology Self-Assessment Program (SAP)
Leadership Positions in Professional SocietiesAmerican College of Cardiology (Chair, Innovations Committee)
DisclosuresConsultant/Advisory BoardBristol Myers Squibb; CPC Clinical Research
Grant/Research SupportNational Heart, Lung, and Blood Institute
Editorial BoardsUpToDate; American College of Cardiology Self-Assessment Program (SAP)
Leadership Positions in Professional SocietiesAmerican College of Cardiology (Chair, Innovations Committee)